发明名称 HSL INHIBITORS USEFUL IN THE TREATMENT OF DIABETES.
摘要 <p>Compounds of formula (I), as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein A1, A2, R1,R2 R3,R4 R5 and R6 have the significance given in claim 1. Objects of the present invention are the compounds of formula (I) and their aforementioned salts and esters and their use as therapeutically active substances, a process for the manufacture of the said compounds, intermediates, pharmaceutical compositions, medicaments containing the said compounds, their pharmaceutically acceptable salts or esters, the use of the said compounds, salts or esters for the treatment or prophylaxis of illnesses, especially in the treatment or prophylaxis of diabetes, metabolic syndrome, dyslipidemia, atherosclerosis or obesity and the use of the said compounds, salts or esters for the production of medicaments for the treatment or prophylaxis of diabetes, metabolic syndrome, dyslipidemia, atherosclerosis or obesity.</p>
申请公布号 MX2012002597(A) 申请公布日期 2012.04.02
申请号 MX20120002597 申请日期 2010.09.07
申请人 F. HOFFMANN-LA ROCHE AG.* 发明人 JEAN ACKERMANN;WERNER NEIDHART;MATTHIAS NETTEKOVEN;AURELIA CONTE;STANLEY WERTHEIMER
分类号 C07D211/62;A61K31/445;A61P3/00;A61P9/10;C07D211/96;C07D401/12;C07D405/12 主分类号 C07D211/62
代理机构 代理人
主权项
地址